-
1
-
-
0037323424
-
Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly acitve antiretroviral therapy
-
Addy CL, Gavrila A, Tsiodras S, et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly acitve antiretroviral therapy. J Clin Endocrinol Metab 2003;88:627-36.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 627-636
-
-
Addy, C.L.1
Gavrila, A.2
Tsiodras, S.3
-
2
-
-
0842303102
-
Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults
-
Badiou S, Merle De Boever C, Dupuy AM, et al. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults. Atherosclerosis 2004;172:273-9.
-
(2004)
Atherosclerosis
, vol.172
, pp. 273-279
-
-
Badiou, S.1
Merle De Boever, C.2
Dupuy, A.M.3
-
3
-
-
0037131318
-
Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia
-
Barrios A, Blanco F, Garcia-Benayas T, et al. Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia. AIDS 2002;16:2079-81.
-
(2002)
AIDS
, vol.16
, pp. 2079-2081
-
-
Barrios, A.1
Blanco, F.2
Garcia-Benayas, T.3
-
4
-
-
0037161026
-
Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance
-
Bastard JP, Caron M, Vidal H, et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002;359:1026-31.
-
(2002)
Lancet
, vol.359
, pp. 1026-1031
-
-
Bastard, J.P.1
Caron, M.2
Vidal, H.3
-
5
-
-
0032797624
-
Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
-
Behrens G, Dejam A, Schmidt H, et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 1999;13:F63-70.
-
(1999)
AIDS
, vol.13
-
-
Behrens, G.1
Dejam, A.2
Schmidt, H.3
-
6
-
-
0033933880
-
Lipodystrophy syndrome in HIV infection: What is it, what causes it and how can it be managed?
-
Behrens GM, Stoll M, Schmidt RE. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf 2000;23:57-76.
-
(2000)
Drug Saf
, vol.23
, pp. 57-76
-
-
Behrens, G.M.1
Stoll, M.2
Schmidt, R.E.3
-
7
-
-
17244372383
-
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
-
Behrens GMN. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005;352:1721-2.
-
(2005)
N Engl J Med
, vol.352
, pp. 1721-1722
-
-
Behrens, G.M.N.1
-
8
-
-
0036840098
-
Impaired glucose phosphorylation and transport in skeletal muscle causes insulin resistance in HIV-1 infected patients with lipodystrophy
-
Behrens GMN, Boerner AR, Weber K, et al. Impaired glucose phosphorylation and transport in skeletal muscle causes insulin resistance in HIV-1 infected patients with lipodystrophy. J Clin Invest 2002;110:1319-27.
-
(2002)
J Clin Invest
, vol.110
, pp. 1319-1327
-
-
Behrens, G.M.N.1
Boerner, A.R.2
Weber, K.3
-
9
-
-
0346992125
-
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: Results from a Norwegian study of 721 patients
-
Bergersen BM, Sandvik L, Dunlop O, et al. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 2003;22:731-6.
-
(2003)
Eur J Clin Microbiol Infect Dis
, vol.22
, pp. 731-736
-
-
Bergersen, B.M.1
Sandvik, L.2
Dunlop, O.3
-
10
-
-
0037456351
-
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection
-
Bozzette SA, Ake CF, Tam HK, et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-10.
-
(2003)
N Engl J Med
, vol.348
, pp. 702-710
-
-
Bozzette, S.A.1
Ake, C.F.2
Tam, H.K.3
-
11
-
-
0033604038
-
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
-
Brinkman K, Smeitink JA, Romijn JA, et al. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 1999;354:1112-5.
-
(1999)
Lancet
, vol.354
, pp. 1112-1115
-
-
Brinkman, K.1
Smeitink, J.A.2
Romijn, J.A.3
-
12
-
-
0038301516
-
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
-
Calza L, Manfredi R, Chiodo F. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS 2003;17:851-9.
-
(2003)
AIDS
, vol.17
, pp. 851-859
-
-
Calza, L.1
Manfredi, R.2
Chiodo, F.3
-
13
-
-
0034987343
-
The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
-
Caron M, Auclair M, Vigouroux C, et al. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 2001;50:1378-88.
-
(2001)
Diabetes
, vol.50
, pp. 1378-1388
-
-
Caron, M.1
Auclair, M.2
Vigouroux, C.3
-
14
-
-
0037333717
-
An objective case definition of lipodystrophy in HIV-infected adults: A case-control study
-
Carr A, Emery S, Law M, et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003;361:726-35.
-
(2003)
Lancet
, vol.361
, pp. 726-735
-
-
Carr, A.1
Emery, S.2
Law, M.3
-
15
-
-
0032493043
-
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
-
Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
-
(1998)
AIDS
, vol.12
-
-
Carr, A.1
Samaras, K.2
Burton, S.3
-
16
-
-
0033583977
-
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
-
Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.
-
(1999)
Lancet
, vol.353
, pp. 2093-2099
-
-
Carr, A.1
Samaras, K.2
Thorisdottir, A.3
-
17
-
-
4444276506
-
Cardio- and cerebrovascular events in HIV-infected persons
-
D'Arminio A, Sabin CA, Phillips AN, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004;18:1811-7.
-
(2004)
AIDS
, vol.18
, pp. 1811-1817
-
-
D'Arminio, A.1
Sabin, C.A.2
Phillips, A.N.3
-
18
-
-
12144287338
-
Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients
-
Driscoll SD, Meininger GE, Lareau MT, et al. Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 2004;18:465-73.
-
(2004)
AIDS
, vol.18
, pp. 465-473
-
-
Driscoll, S.D.1
Meininger, G.E.2
Lareau, M.T.3
-
19
-
-
2442566522
-
Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients
-
Driscoll SD, Meininger GE, Ljungquist K, et al. Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2004;89:2171-8.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2171-2178
-
-
Driscoll, S.D.1
Meininger, G.E.2
Ljungquist, K.3
-
20
-
-
0042832397
-
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
-
Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003;37:613-27.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 613-627
-
-
Dube, M.P.1
Stein, J.H.2
Aberg, J.A.3
-
21
-
-
0345064200
-
Combination antiretroviral therapy and the risk of myocardial infarction
-
Friis-Moller N, Sabin CA, et al., for the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
-
(2003)
N Engl J Med
, vol.349
, pp. 1993-2003
-
-
Friis-Moller, N.1
Sabin, C.A.2
-
22
-
-
0036828824
-
Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy
-
Gan SK, Samaras K, Thompson CH, et al. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 2002;51:3163-9.
-
(2002)
Diabetes
, vol.51
, pp. 3163-3169
-
-
Gan, S.K.1
Samaras, K.2
Thompson, C.H.3
-
23
-
-
0042769119
-
Hypertension among HIV patients: Prevalence and relationships to insulin resistance and metabolic syndrome
-
Gazzaruso C, Bruno R, Garzaniti A, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens 2003;21:1377-82.
-
(2003)
J Hypertens
, vol.21
, pp. 1377-1382
-
-
Gazzaruso, C.1
Bruno, R.2
Garzaniti, A.3
-
24
-
-
3943052088
-
Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy
-
Gerber MT, Mondy KE, Yarasheski KE, et al. Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy. Clin Infect Dis 2004;39:419-25.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 419-425
-
-
Gerber, M.T.1
Mondy, K.E.2
Yarasheski, K.E.3
-
25
-
-
11344293751
-
Cardiovascular risk and body-fat abnormalites in HIV-infected patients
-
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalites in HIV-infected patients. N Engl J Med 2005;352:48-62.
-
(2005)
N Engl J Med
, vol.352
, pp. 48-62
-
-
Grinspoon, S.1
Carr, A.2
-
26
-
-
0035092690
-
Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance
-
Hadigan C, Meigs JB, Rabe J, et al. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 2001;86:939-43.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 939-943
-
-
Hadigan, C.1
Meigs, J.B.2
Rabe, J.3
-
27
-
-
1642580535
-
Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection
-
Hsue PY, Giri K, Erickson S, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004;109:316-9.
-
(2004)
Circulation
, vol.109
, pp. 316-319
-
-
Hsue, P.Y.1
Giri, K.2
Erickson, S.3
-
28
-
-
0035288396
-
Antiretroviral therapy and the lipodystrophy syndrome
-
John M, Nolan D, Mallal S. Antiretroviral therapy and the lipodystrophy syndrome. Antiviral Ther 2001;6:9-20.
-
(2001)
Antiviral Ther
, vol.6
, pp. 9-20
-
-
John, M.1
Nolan, D.2
Mallal, S.3
-
29
-
-
0042732970
-
Expression of adipogenic transcription factors. Peroxisome proliferator-activated receptor gamma co-activator, IL-6, and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy
-
Kannisto K, Sutinen J, Korsheninnikova E, et al. Expression of adipogenic transcription factors. Peroxisome proliferator-activated receptor gamma co-activator, IL-6, and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 2003;17:1753-62.
-
(2003)
AIDS
, vol.17
, pp. 1753-1762
-
-
Kannisto, K.1
Sutinen, J.2
Korsheninnikova, E.3
-
30
-
-
0036236967
-
Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy
-
Koppel K, Bratt G, Schulman S, et al. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;29:441-9.
-
(2002)
J Acquir Immune Defic Syndr
, vol.29
, pp. 441-449
-
-
Koppel, K.1
Bratt, G.2
Schulman, S.3
-
31
-
-
0037677691
-
HIV protease inhibitors acutely impair glucose-stimulated insulin release
-
Koster JC, Remedi MS, Qiu H, et al. HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 2003;52:1695-700.
-
(2003)
Diabetes
, vol.52
, pp. 1695-1700
-
-
Koster, J.C.1
Remedi, M.S.2
Qiu, H.3
-
32
-
-
25444445951
-
Recombinant human growth hormone enhances patient-reported body image and improves quality of life in HIV-associated adipose redistribution
-
Kotler DP, Turner R, Su M, et al. Recombinant human growth hormone enhances patient-reported body image and improves quality of life in HIV-associated adipose redistribution. Antiviral Ther 2003;8:L59.
-
(2003)
Antiviral Ther
, vol.8
-
-
Kotler, D.P.1
Turner, R.2
Su, M.3
-
33
-
-
0035661381
-
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlpidemia
-
Liang JS, Distler O, Cooper DA, et al. HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlpidemia. Nat Med 2001;7:1327-31.
-
(2001)
Nat Med
, vol.7
, pp. 1327-1331
-
-
Liang, J.S.1
Distler, O.2
Cooper, D.A.3
-
34
-
-
3242747137
-
Increased expression of TNFα, IL-6, and IL-8 in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin
-
Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNFα, IL-6, and IL-8 in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin. Am J Physiol Endocrinol Metab 2004;86:E8-13.
-
(2004)
Am J Physiol Endocrinol Metab
, vol.86
-
-
Lihn, A.S.1
Richelsen, B.2
Pedersen, S.B.3
-
35
-
-
0033924871
-
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
-
Mallal SA, John M, Moore CB, et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000;14:1309-16.
-
(2000)
AIDS
, vol.14
, pp. 1309-1316
-
-
Mallal, S.A.1
John, M.2
Moore, C.B.3
-
36
-
-
0038708272
-
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
-
Mallon PWG, Miller J, Cooper DA, et al. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 2003;17:971-9.
-
(2003)
AIDS
, vol.17
, pp. 971-979
-
-
Mallon, P.W.G.1
Miller, J.2
Cooper, D.A.3
-
37
-
-
1642403331
-
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men
-
Mary-Krause M, Cotte L, Simon A, et al. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003;17:2479-86.
-
(2003)
AIDS
, vol.17
, pp. 2479-2486
-
-
Mary-Krause, M.1
Cotte, L.2
Simon, A.3
-
38
-
-
0036182863
-
Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution
-
Meininger G, Hadigan C, Laposata M, et al. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism 2002;51:260-6.
-
(2002)
Metabolism
, vol.51
, pp. 260-266
-
-
Meininger, G.1
Hadigan, C.2
Laposata, M.3
-
39
-
-
0037045056
-
A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia
-
Miller J, Brown D, Amin J, et al. A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia. AIDS 2002;16:2195-200.
-
(2002)
AIDS
, vol.16
, pp. 2195-2200
-
-
Miller, J.1
Brown, D.2
Amin, J.3
-
40
-
-
21144450815
-
Switching to atazanavir improves metabolic disorders in patients with severe hyperlipidemia
-
Möbius U, Lubach-Ruitman M, Castro-Frenzel B, et al. Switching to atazanavir improves metabolic disorders in patients with severe hyperlipidemia. J Acquir Immune Defic Syndr 2005;39:174-80.
-
(2005)
J Acquir Immune Defic Syndr
, vol.39
, pp. 174-180
-
-
Möbius, U.1
Lubach-Ruitman, M.2
Castro-Frenzel, B.3
-
41
-
-
0037066357
-
Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations
-
Murata H, Hruz PW, Mueckler M. Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. AIDS 2002;16:859-63.
-
(2002)
AIDS
, vol.16
, pp. 859-863
-
-
Murata, H.1
Hruz, P.W.2
Mueckler, M.3
-
42
-
-
0035666441
-
Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis
-
Nolan D, John M, Mallal S. Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis. Antiviral Ther 2001;6:145-60.
-
(2001)
Antiviral Ther
, vol.6
, pp. 145-160
-
-
Nolan, D.1
John, M.2
Mallal, S.3
-
43
-
-
0035805218
-
Metabolic effects of indinavir in healthy HIV-seronegative men
-
Noor MA, Lo JC, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 2001;15:F11-8.
-
(2001)
AIDS
, vol.15
-
-
Noor, M.A.1
Lo, J.C.2
Mulligan, K.3
-
44
-
-
0037192590
-
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study
-
Noor MA, Seneviratne T, Aweeka FT, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS 2002;16:F1-8.
-
(2002)
AIDS
, vol.16
-
-
Noor, M.A.1
Seneviratne, T.2
Aweeka, F.T.3
-
45
-
-
0033963686
-
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
-
Purnell JQ, Zambon A, Knopp RH, et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 2000;14:51-7.
-
(2000)
AIDS
, vol.14
, pp. 51-57
-
-
Purnell, J.Q.1
Zambon, A.2
Knopp, R.H.3
-
46
-
-
2942655667
-
Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy
-
Rao A, D'Amico S, Balasubramanyam A, et al. Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy. Am J Med Sci 2004;327:315-8.
-
(2004)
Am J Med Sci
, vol.327
, pp. 315-318
-
-
Rao, A.1
D'Amico, S.2
Balasubramanyam, A.3
-
47
-
-
0012570692
-
Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
-
Saint-Marc T, Partisani M, Poizot-Martin I, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000;14:37-49.
-
(2000)
AIDS
, vol.14
, pp. 37-49
-
-
Saint-Marc, T.1
Partisani, M.2
Poizot-Martin, I.3
-
48
-
-
0035914028
-
Elevated blood pressure in subjects with lipodystrophy
-
Sattler FR, Qian D, Louie S, et al. Elevated blood pressure in subjects with lipodystrophy. AIDS 2001;15:2001-10.
-
(2001)
AIDS
, vol.15
, pp. 2001-2010
-
-
Sattler, F.R.1
Qian, D.2
Louie, S.3
-
49
-
-
0036840147
-
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS-Society-USA panel
-
Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS-Society-USA panel. J Acquir Immune Defic Syndr 2002;31:257-75.
-
(2002)
J Acquir Immune Defic Syndr
, vol.31
, pp. 257-275
-
-
Schambelan, M.1
Benson, C.A.2
Carr, A.3
-
50
-
-
20644450805
-
Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003
-
Seaberg EC, Munoz A, Lu M, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005;19:953-60.
-
(2005)
AIDS
, vol.19
, pp. 953-960
-
-
Seaberg, E.C.1
Munoz, A.2
Lu, M.3
-
52
-
-
3142546243
-
Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors
-
Stein JH, Merwood MA, Bellehumeur JL, et al. Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors. Am Heart J 2004;147:E18.
-
(2004)
Am Heart J
, vol.147
-
-
Stein, J.H.1
Merwood, M.A.2
Bellehumeur, J.L.3
-
53
-
-
0043157304
-
Rosiglitazone in the treatment of HAART-associated lipodystrophy - A randomized double-blinded placebo controlled study
-
Sutinen J, Hakkinen AM, Westerbacka J, et al. Rosiglitazone in the treatment of HAART-associated lipodystrophy - a randomized double-blinded placebo controlled study. Antiviral Ther 2003;8:199-207.
-
(2003)
Antiviral Ther
, vol.8
, pp. 199-207
-
-
Sutinen, J.1
Hakkinen, A.M.2
Westerbacka, J.3
-
54
-
-
0035834508
-
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways
-
Van der Valk M, Bisschop PH, Romijn JA, et al. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS 2001;15:2093-100.
-
(2001)
AIDS
, vol.15
, pp. 2093-2100
-
-
Van Der Valk, M.1
Bisschop, P.H.2
Romijn, J.A.3
-
55
-
-
0032558803
-
Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
-
Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998;12:167-73.
-
(1998)
AIDS
, vol.12
, pp. 167-173
-
-
Walli, R.1
Herfort, O.2
Michl, G.M.3
-
56
-
-
0037390373
-
Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy
-
Yki-Jarvinen H, Sutinen J, Silveira A, et al. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol 2003;23:688-94.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 688-694
-
-
Yki-Jarvinen, H.1
Sutinen, J.2
Silveira, A.3
-
57
-
-
4744363012
-
Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy
-
Young EM, Considine RV, Sattler FR, et al. Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy. Cardiovasc Toxicol 2004;4:179-86.
-
(2004)
Cardiovasc Toxicol
, vol.4
, pp. 179-186
-
-
Young, E.M.1
Considine, R.V.2
Sattler, F.R.3
|